drug · small molecule
patient view →DYANAVEL XR 20
Marketedupdated 2mo agoby $TRAW Traws Pharma, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for attention deficit hyperactivity disorder and 3 investigational indications.
targets
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
all catalysts(6)
approval · 6
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that